Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 13-24 of 1214 results.
"With no observed instances of infiltration, extravasation, or other related complications, peripheral administration of vasopressin initiated in the ED for select, hemodynamically compromised patients may represent a feasible approach to initiate early vasopressor therapy while allowing clinicians to more carefully weigh the risks and benefits of CVC placement" McCurry et al (2025).
"The DIVA-SP is useful, valid and reliable for application in Spain. Furthermore, it exhibits better psychometric properties than the original version for identifying difficult intravenous access in pediatric patients" de la Vieja-Soriano et al (2025).
"To evaluate the effectiveness of saline, heparin, and vitamin C solutions in unclogging neonatal central venous catheters occluded by clots" Mathiolli et al (2025).
"IV iron is a safe and effective option for older adults, offering reliable and rapid repletion when oral iron is ineffective or contraindicated. Clinicians must weigh benefits and risks to optimize outcomes" Chen and Cardone (2025).
"This study was conducted with the aim of determining the complications and dwell time of PICs with and without splints in infants admitted to the neonatal intensive care unit" Shirdel et al (2025).
"Piperacillin/tazobactam (P/T) is a broad-spectrum β-lactam antibiotic frequently used in outpatient parenteral antimicrobial therapy programs (OPAT). We aim to compare the clinical outcomes of P/T treatment in two models of OPAT care in order to maximize the utilization of health resources" Lora-Escobar et al (2025).
"When bloodstream infection (BSI) occurs in patients with a central venous catheter (CVC), the catheter may be the original source (catheter-related, CR) or may become a source for persistent infection. BSI should prompt an evaluation of CVC necessity, but there are challenges associated with CVC replacement" Buskandar et al (2025).
"Peripheral hypertonic saline is a safe alternative to CVC placement, particularly in urgent situations where rapid intervention is required. Low complication rates support its broader use in clinical practice, enabling timely treatment while minimizing the risks associated with central access" Huang et al (2025).
"UVC placement appears to be superior to PICC as the first venous access in preterm infants during the early postnatal period. PICC placement may be less advantageous in the first days of life due to a smaller catheter diameter, technical difficulty, and longer insertion time" Okur et al (2025).
"This study aimed to assess the feasibility of giving IV antibiotics using EMPs to adult inpatients and to identify barriers and facilitators for their implementation" Spencer-Jones et al (2025).
"The removal of a central venous catheter can cause serious complications, such as air embolism, but there is limited evidence on effective prevention methods" Benetti et al (2025).
"The OPAT programme optimized antimicrobial use and reduced IV therapy duration, adverse clinical outcomes, and healthcare costs" Manders et al (2025).
